Vertex to Announce Second Quarter 2024 Financial Results on August 1

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets close. The company will host a conference call and webcast

Businesswire04:05

$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 6.43% on an annualized basis producing an average annual return of 19.36%. Currently, Vertex Pharmaceuticals

Benzinga02:30

"Interest rate cuts + Trump's return" two major expectations continue to ferment! Will this benefiting sector see the dawn?

Market participants believe that in recent three years, the biotechnology sector has been underperforming the broader market. Once the expectation of interest rate cuts is raised by the Fed, biotechnology companies, represented by innovative drugs, will have the ability to make up ground.

Futu NewsJul 1 20:07

Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space

Seeking AlphaJun 29 23:35

Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares

On June 26, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.

Yahoo FinanceJun 29 15:07

Vertex Pharmaceuticals(VRTX.US) Officer Sells US$1.08 Million in Common Stock

$Vertex Pharmaceuticals(VRTX.US)$ Officer Bozic Carmen sold 2,280 shares of common stock on Jun 26, 2024 at an average price of $471.72 for a total value of $1.08 million.Source: Announcement What is

Futu NewsJun 29 04:47